Ann: Immutep receives A$1.9M from French R&D tax cash rebate, page-3

Immutep Ltd (IMM) has received a A$1,910,010 cash rebate from the French Government under its Crédit d’Impôt Recherche (CIR) scheme, a tax incentive by which French companies - Immutep qualifies to receive CIR credits through its subsidiary Immutep S.A.S. - conducting research and development activities in Europe can be reimbursed 30% of their eligible expenditure. The funds will be used to support the ongoing and planned global clinical development of eftilagimod alpha and the preclinical development of IMP761

http://crweworld.com/article/news-p...nt-related-tax-rebate-from-french-government-